• Ann Tucker

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

TUESDAY, MARCH 2nd / 12:00-1:00pm CT

Overdose deaths associated with illicit stimulants have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent on stimulants, new treatments utilizing readily available medications are showing encouraging empirical support.

Join the National Council for Behavioral Health as we examine the latest groundbreaking research in the context of current increases in stimulant use. Register here

4 views0 comments

Recent Posts

See All

This week, the House Committee on Energy & Commerce met to markup six health-related bills, including the Restoring Hope for Mental Health and Well-Being Act of 2022, which would reauthorize key SAMHS